Microbes and their Role in Atrial Fibrillation: A Literature Review
DOI:
https://doi.org/10.24207/jca.v37i1.3496Abstract
Atrial fibrillation (AF) is a prevalent cardiac arrhythmia observed in clinical practice. The gut microbiota (GM) and their byproducts have the potential to activate the autonomic nervous system, which plays a crucial role in the development and maintenance of AF. Recent hypotheses suggest that bacterial infections, such as Helicobacter pylori and Chlamydia pneumonia might play a role in the development of AF. The emerging evidence suggested that certain patients might develop AF due to bacterial infections. AF patients exhibited a significant increase in species richness and diversity. Specifically, opportunistic pathogenic bacteria such as Klebsiella, Haemophilus, Streptococcus and Enterococcus were significantly higher, while symbiotic bacteria such as Agathobacter and Butyrivibrio were significantly lower in AF patients. Likewise, the development of AF has been linked to infections caused by viruses that have an affinity for the heart. Chronic hepatitis C virus infection appears to be linked to an elevated risk of incidental AF, likely due to the shared underlying pathology of chronic inflammation. Numerous studies have explored the arrhythmogenic effects of SARS-CoV-2, particularly its impact on mortality and its association with AF. Influenza infection was found to be significantly linked to the development of AF, resulting in an 18% increased risk. However, in cases where AF is present and dengue infection is suspected, it is advisable to exercise caution when considering the use of anticoagulants, ensuring that specific serological tests have excluded the presence of this infection.
Downloads
References
Lindberg T, Wimo A, Elmst Hl S, Qiu C, Bohman D M, Sanmartin Berglund J. Prevalence and incidence of atrial fibrillation and other arrhythmias in the general older population: findings from the swedish national study on aging and care. Gerontol Geriatr Med. 2019;5:1–8. https://doi.org/10.1177%2F2333721419859687 DOI: https://doi.org/10.1177/2333721419859687
Kotecha D, Piccini JP. Atrial fibrillation in heart failure: what should we do? Eur Heart J. 2015;36:3250–7. https://doi.org/10.1093/eurheartj/ehv513 DOI: https://doi.org/10.1093/eurheartj/ehv513
Kaplan RM, Koehler J, Ziegler PD, Sarkar S, Zweibel S, Passman RS. Stroke risk as a function of atrial fibrillation duration and CHA2DS2-VASc score. Circulation. 2019;140:1639–46. https://doi.org/10.1161/CIRCULATIONAHA.119.041303 DOI: https://doi.org/10.1161/CIRCULATIONAHA.119.041303
Drexler, M. Institute of Medicine. Prevention and Treatment. In: What You Need to Know About Infectious Disease. Washington, DC: National Academies Press; 2010.
Fan H, Liu X, Ren Z, Fei X, Luo J, Yang X, et al. Gut microbiota and cardiac arrhythmia. Frontiers in Cellular and Infection Microbiology. 2023;13:1147687. https://doi.org/10.3389%2Ffcimb.2023.1147687 DOI: https://doi.org/10.3389/fcimb.2023.1147687
Palmu J, Börschel CS, Ortega-Alonso A, Markó L, Inouye M, Jousilahti P, et al. Gut microbiome and atrial fibrillation—results from a large population-based study. EBioMedicine. 2023;91. https://doi.org/10.1016/j.ebiom.2023.104583 DOI: https://doi.org/10.1016/j.ebiom.2023.104583
Yu L, Meng G, Huang B, Zhou X, Stavrakis S, Wang M, et al. A potential relationship between gut microbes and atrial fibrillation: trimethylamine N-oxide, a gut microbe-derived metabolite, facilitates the progression of atrial fibrillation. International journal of cardiology. 2018;255:92-8. https://doi.org/10.1016/j.ijcard.2017.11.071 DOI: https://doi.org/10.1016/j.ijcard.2017.11.071
Andrew P, Montenero AS. Is there a link between atrial fibrillation and certain bacterial infections?. Journal of cardiovascular medicine. 2007;8(12):990-6. https://doi.org/10.2459/jcm.0b013e32801411e5 DOI: https://doi.org/10.2459/JCM.0b013e32801411e5
Huang K, Wang Y, Bai Y, Luo Q, Lin X, Yang Q, et al. Gut Microbiota and Metabolites in Atrial Fibrillation Patients and Their Changes after Catheter Ablation. Microbiol Spectr. 2022;10(2):e0107721. https://doi.org/10.1128/spectrum.01077-21 DOI: https://doi.org/10.1128/spectrum.01077-21
Lu D, Zou X, Zhang H. The Relationship between Atrial Fibrillation and Intestinal Flora with Its Metabolites. Frontiers in Cardiovascular Medicine. 2022;9. https://doi.org/10.3389/fcvm.2022.948755 DOI: https://doi.org/10.3389/fcvm.2022.948755
Zuo K, Li J, Wang P, Liu Y, Liu Z, Yin X, et al. Duration of persistent atrial fibrillation is associated with alterations in human gut microbiota and metabolic phenotypes. Msystems. 2019;4(6):e00422-19. https://doi.org/10.1128%2FmSystems.00422-19 DOI: https://doi.org/10.1128/msystems.00422-19
Drapkina OM, Yafarova AA, Kaburova AN, Kiselev AR. Targeting Gut Microbiota as a Novel Strategy for Prevention and Treatment of Hypertension, Atrial Fibrillation and Heart Failure: Current Knowledge and Future Perspectives. Biomedicines. 2022;10(8):2019. https://doi.org/10.3390/biomedicines10082019 DOI: https://doi.org/10.3390/biomedicines10082019
Al-Kaisey AM, Figgett W, Hawson J, Mackay F, Joseph SA, Kalman JM. Gut Microbiota and Atrial Fibrillation: Pathogenesis, Mechanisms and Therapies, Arrhythmia & Electrophysiology Review 2023;12:e14. https://doi.org/10.15420/aer.2022.33 DOI: https://doi.org/10.15420/aer.2022.33
Abdalla LF, Santos JH, Barreto RT, D’Assunção FF, Borges MA, Nascimento VA, et al. Atrial fibrillation in a patient with Zika virus infection. Virology journal. 2018;15(1):1-6. https://doi.org/10.1186/s12985-018-0938-2 DOI: https://doi.org/10.1186/s12985-018-0938-2
Wu L, Emmens RW, van Wezenbeek J, Stooker W, Allaart CP, Vonk AB, et al. The presence of cardiotropic viral genomes is not increased in atrial tissue of atrial fibrillation patients. Netherlands Heart Journal. 2022;30(7-8):377-82. https://doi.org/10.1007/ s12471-022-01660-4 DOI: https://doi.org/10.1007/s12471-022-01660-4
Ichiki H, Orihara K, Hamasaki S, Ishida S, Oketani N, Iriki Y, et al. The role of infection in the development of non-valvular atrial fibrillation: up-regulation of Toll-like receptor 2 expression levels on monocytes. Journal of cardiology. 2009;53(1):127-35. https://doi.org/10.1016/j.jjcc.2008.09.008 DOI: https://doi.org/10.1016/j.jjcc.2008.09.008
Yang YH, Chiang HJ, Yip HK, Chen KJ, Chiang JY, Lee MS, et al. Risk of new-onset atrial fibrillation among asian chronic hepatitis C virus carriers: a nationwide population-based cohort study. Journal of the American Heart Association. 2019;8(22):e012914. https://doi.org/10.1161/jaha.119.012914 DOI: https://doi.org/10.1161/JAHA.119.012914
Chang TY, Chao TF, Liu CJ, Chen SJ, Chung FP, Liao JN, et al. The association between influenza infection, vaccination, and atrial fibrillation: A nationwide case-control study. Heart rhythm. 2016;13(6):1189-94. https://doi.org/10.1016/j.hrthm.2016.01.026 DOI: https://doi.org/10.1016/j.hrthm.2016.01.026
Chiang CH, Huang CC, Chan WL, Huang PH, Chen YC, Chen TJ, et al. Herpes simplex virus infection and risk of atrial fibrillation: a nationwide study. International journal of cardiology. 2013;164(2):201-4. https://doi.org/10.1016/j.ijcard.2011.06.126 DOI: https://doi.org/10.1016/j.ijcard.2011.06.126
Aghenta A, Osowo A, Thomas J. Symptomatic atrial fibrillation with infectious mononucleosis. Can Fam Physician. 2008 [cited 2023 Jun 5];54(5):695–696. Available from: https://pubmed.ncbi.nlm.nih.gov/18474702/
Takano H, Nakagawa K, Ishio N, Daimon M, Daimon M, Kobayashi Y, et al. Active myocarditis in a patient with chronic active Epstein-Barr virus infection. Int J Cardiol. 2008;130(1):e11–e13. https://doi.org/10.1016/j.ijcard.2007.07.040 DOI: https://doi.org/10.1016/j.ijcard.2007.07.040
Cha MJ, Seo HM, Choi EK, Lee JH, Han K, Lee SR, et al. Increased risk of atrial fibrillation in the early period after herpes zoster infection: a nationwide population-based case-control study. Journal of Korean medical science. 2018;33(22):e160. https://doi.org/10.3346/jkms.2018.33.e160 DOI: https://doi.org/10.3346/jkms.2018.33.e160
Veloso HH, Ferreira Júnior JA, Paiva JM, Honório JF, Bellei NC, Paola AA. Acute atrial fibrillation during dengue hemorrhagic fever. Brazilian Journal of Infectious Diseases. 2003;7:418-22. https://doi.org/10.1590/S1413-86702003000600010 DOI: https://doi.org/10.1590/S1413-86702003000600010
Pranata R, Wiharja W, Damay V. Atrial Fibrillation in Dengue Infection: A Self-limiting Phenomenon?(Two Case Reports). ACI (Acta Cardiologia Indonesiana). 2018;4(1):36-40. https://doi.org/10.22146/aci.36637 DOI: https://doi.org/10.22146/aci.36637
Lee PY, Garan H, Wan EY, Scully BE, Biviano A, Yarmohammadi H. Cardiac arrhythmias in viral infections. J Interv Card Electrophysiol. 2023:1–15. https://doi.org/10.1007%2Fs10840-023-01525-9
Hui DS, Azhar EI, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health—The latest 2019 novel coronavirus outbreak in Wuhan, China. International journal of infectious diseases. 2020;91:264-6. https://doi.org/10.1016%2Fj.ijid.2020.01.009 DOI: https://doi.org/10.1016/j.ijid.2020.01.009
Khan MZ, Zahid S, Franklin S, Saeed J, Figueredo VM, et al. Management of Uncontrolled Atrial Fibrillation in COVID Patient. Int Arch Intern Med. 2021;5:033. https://doi.org/10.23937/2643-4466/1710033 DOI: https://doi.org/10.23937/2643-4466/1710033
Rosenblatt AG, Ayers CR, Rao A, Howell SJ, Hendren NS, Zadikany RH, et al. New-onset atrial fibrillation in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 Cardiovascular Registry. Circ Arrhythm Electrophysiol. 2022;15(5):e010666. https://doi.org/10.1161/circep.121.010666 DOI: https://doi.org/10.1161/CIRCEP.121.010666
Mountantonakis SE, Saleh M, Fishbein J, Gandomi A, Lesser M, Chelico J, et al. Atrial fibrillation is an independent predictor for inhospital mortality in patients admitted with SARS-CoV-2 infection. Heart Rhythm. 2021;18(4):501–507. https://doi.org/10.1016/j.hrthm.2021.01.018 DOI: https://doi.org/10.1016/j.hrthm.2021.01.018
Li Z, Shao W, Zhang J, Ma J, Huang S, Yu P, et al. Prevalence of atrial fibrillation and associated mortality among hospitalized patients with COVID-19: a systematic review and meta-analysis. Front Cardiovasc Med. 2021;8:720129. https://doi.org/10.3389/fcvm.2021.72012912 DOI: https://doi.org/10.3389/fcvm.2021.720129
Peltzer B, Manocha KK, Ying X, Kirzner J, Ip JE, Thomas G, et al. Arrhythmic complications of patients hospitalized with COVID-19: incidence, risk factors, and outcomes. Circ Arrhythm Electrophysiol. 2020;13(10):e009121. https://doi.org/10.1161/circep.120.009121 DOI: https://doi.org/10.1161/CIRCEP.120.009121
Stone E, Kiat H, McLachlan CS. Atrial fibrillation in COVID-19: A review of possible mechanisms. The FASEB Journal. 2020;34(9):11347-54. https://doi.org/10.1096/fj.202001613 DOI: https://doi.org/10.1096/fj.202001613
Russo V, Silverio A, Scudiero F, D’Andrea A, Attena E, Di Palma G, et al. Clinical outcome of hospitalized COVID-19 patients with history of atrial fibrillation. Medicina. 2022;58(3):399. https://doi.org/10.3390/medicina58030399 DOI: https://doi.org/10.3390/medicina58030399
Gómez JA, Pérez-Belmonte LM, Rubio-Rivas M, Bascuñana J, Quirós-López R, Martínez ML, et al. Mortality risk factors in patients with SARS-CoV-2 infection and atrial fibrillation: Data from the SEMI-COVID-19 registry. Medicina Clínica (English Edition). 2022;159(10):457-64. https://doi.org/10.1016/j.medcli.2022.01.008 DOI: https://doi.org/10.1016/j.medcle.2022.01.020
Zakynthinos GE, Tsolaki V, Karavidas N, Vazgiourakis V, Dimeas G, Mantzarlis K, et al. Secondary bacterial infections are a leading factor triggering New Onset Atrial Fibrillation in intubated ICU Covid-19 ARDS patients. Journal of Infection and Public Health. 2022;15(7):766-72. https://doi.org/10.1016/j.jiph.2022.06.006 DOI: https://doi.org/10.1016/j.jiph.2022.06.006
Maloberti A, Giannattasio C, Rebora P, Occhino G, Ughi N, Biolcati M, et al. Incident Atrial Fibrillation and In-Hospital Mortality in SARS-CoV-2 Patients. Biomedicines. 2022;10(8):1940. https://doi.org/10.3390/biomedicines10081940 DOI: https://doi.org/10.3390/biomedicines10081940
Genovesi S, Rebora P, Occhino G, Rossi E, Maloberti A, Belli M, et al. Atrial Fibrillation and Clinical Outcomes in a Cohort of Hospitalized Patients with Sars-Cov-2 Infection and Chronic Kidney Disease. J Clin Med. 2021;10(18):4108. https://doi.org/10.3390/jcm10184108 DOI: https://doi.org/10.3390/jcm10184108
